
An over 31 per cent cut on ad spends, a portfolio prioritisation exercise and unlocking of synergies from the nutrition business (with Horlicks becoming part of its portfolio with the completion of the GSK acqusition) has helped FMCG major, Hindustan Unilever registered a 4.4 per cent increase in sales in Q1 FY21. The revenue from the quarter is Rs 10,560 crore, while the net profit grew by 7 per cent at Rs 1,881 crore. The company's volume growth declined by 7 per cent, excluding the GSK volume. The biggest gainer has been the company's food and refreshment business which saw a 52 per cent growth, while home care de-grew by 2 per cent and beauty and personal care underwent a 12 per cent de-growth. "Health, hygiene and nutrition constitute 80 per cent of our business and that has grown by 6 per cent, despite supply led constraints," says Sanjiv Mehta, Chairman and MD, Hindustan Unilever. He says that consumption sentiments would dramatically improve only when a vaccine for the coronavirus is discovered.
ALSO READ: HUL Q1 profit rises 7% to Rs 1,881 crore, sales up 4%